Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast

© Renub Research Page 1 of 15

Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast

Renub Researchwww.renub.com

Published: April, 2015Copyright © 2015 Renub Research – All Rights Reserved


Canada Pediatric Vaccines Market Analysis

Pediatric vaccines market continues to be the success story for the manufacturers of pediatric

vaccines in Canada. The value of the Canada pediatric vaccines market is expected to be

slightly less than US$ 2 Billion by 2020. Pneumococcal vaccines (PCV) and Varicella vaccines

are the leading market share holder in Canada and together they contribute more than 50% of

the total Pediatric vaccines market. Polio, Measles, Mumps & Rubella (MMR), Diphtheria,

Tetanus & Pertussis (DTaP) cases have shown diminishing trends from the year 2001 till 2013.

On the contrary, in terms of Doses, Diphtheria, Tetanus & Pertussis(DTaP) and

Pneumococcal vaccines (PCV) have the highest number of doses in 2014.Diphtheria, Tetanus &

Pertussis(DTap) and Polio are the highly penetrated vaccines in Canada pediatric vaccines

market in 2014. It is predicted that these two vaccines will bolster the usable pattern in

Canada. Canada Pediatric vaccines are expected to remain highly active in the future, fueled

by the encouragement and financing from Governments and other health organizations. Canada

Pediatric vaccines market is driven by favorable demographics, growing public acceptance and

product innovation.

This is Renub Research 7th edition report on Vaccines Market & 2nd edition on Pediatric

Vaccines Sector. Report titled "Canada Pediatric Vaccines Market, Doses, Immunization

(Vaccinated), Cases & Forecast” talks about the pediatric vaccines scenario in Canada. This

report provides information on Eight (8) segments of Pediatric Vaccines Market, Pediatric

Vaccines Doses, Pediatric Vaccines number of Children Being Vaccinated and Number of Cases

in Canada. This report covers in detail all aspects of Past, Present and Future Scenario. The

report also entails major factors driving the Pediatric Vaccines Market and Challenges of

Canada Pediatric Vaccines Market.

8 Pediatric Vaccines Covered in this Report are as follows:

1. Measles, Mumps & Rubella (MMR) Vaccines

2. Haemophilus Influenzae Type B (HIB) Vaccines

3. Polio Vaccines

4. Diphtheria, Tetanus & Pertussis (DTaP) Vaccines

5. Pneumococcal Vaccines


6. Hepatitis B Pediatric Vaccines

7. Varicella / Chicken Pox Vaccines

8. Meningococcal C Conjugate (Men–C) Vaccines

All the Pediatric Vaccines in this Report have been studied from Four View Points:

Number of Cases

Number of Doses

Number of Children Being Vaccinated

Market Size for all 8 Pediatric Vaccines

Data Sources

This report is built using data and information sourced from proprietary databases, primary and

secondary research and in–house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non–

printable sources like search engines, News websites, Government websites, Trade Journals,

White Papers, Government Agencies, Magazines, Newspapers, Trade Associations, Books,

Industry Portals, Industry Associations and access to more than 500 paid databases.


About Us

RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long–term experience especially in

international Business–to–Business Researches, Surveys, Business and Consulting. Throughout

the years we have acquired expertise in most market sectors, including Information Technology

(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,

Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer

Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and

Ph.D. degrees in Finance, Marketing, Human Resource, Bio–Technology, Medicine, Information

Technology, Environmental Science and many more. Our research help make the business

decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We

support many blue chip companies by providing them findings and perspectives across a wide

range of markets. Our research reports offer a blend of information insight, analysis and

forecasting that is essential in today’s ultra–competitive markets.

For more information on us or to view any of our sample work you can mail

us at [email protected]

mailto:[email protected]


Published

By

RReennuubb RReesseeaarrcchh

A–116B, Sector–27

Noida – 201301

Phone: +91–120–421–9822, 254–5750 (India)

+1–678–302–0700 (USA)

Fax : +91–120–424–9780

Email: [email protected]

Website: www.renub.com

© Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast

Renub Research, 2015

Edition 2.0

All rights reserved. This publication is protected

by copyright. No part of it may be reproduced, stored

in a retrieval system or transmitted, in any form or by

any means, electronic mechanical, photocopying,

recording or otherwise without the prior written

permission of the publishers


http://www.renub.com/


Table of Contents

1. Executive Summary

2. Canada – Pediatric Vaccines Market & Forecast

3. Canada – Pediatric Vaccines Market Share & Forecast

4. Canada – Pediatric Vaccines Cases, Doses, Immunization Coverage, Market & Forecast

4.1 Canada – Measles, Mumps & Rubella (MMR) Vaccines & Forecast

4.1.1 Number of Measles, Mumps & Rubella (MMR) Cases

4.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses

4.1.3 Measles, Mumps & Rubella (MMR) – Number of Children Being Vaccinated

4.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines

4.2 Canada – Haemophilus Influenzae Type B (HIB) Vaccines & Forecast

4.2.1 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses

4.2.2 Haemophilus Influenzae Type B (HIB) – Number of Children Being Vaccinated

4.2.3 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines

4.3 Canada – Polio Vaccines & Forecast

4.3.1 Number of Polio Cases

4.3.2 Number of Polio Vaccines Doses

4.3.3 Polio Vaccines – Number of Children Being Vaccinated

4.3.4 Market Size of Polio Vaccines

4.4 Canada – Diphtheria, Tetanus & Pertussis (DTaP) Vaccines & Forecast

4.4.1 Number of Diphtheria, Tetanus & Pertussis (DTaP) Cases

4.4.2 Number of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Doses

4.4.3 Diphtheria, Tetanus & Pertusis (DTaP) – Number of Children Being Vaccinated

4.4.4 Market Size of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines

4.5 Canada – Pneumococcal Vaccines & Forecast

4.5.1 Number of Pneumococcal Vaccines Doses

4.5.2 Pneumococcal – Number of Children Being Vaccinated

4.5.3 Market Size of Pneumococcal Vaccines

4.6 Canada – Hepatitis B Pediatric Vaccines & Forecast

4.6.1 Number of Hepatitis B Pediatric Vaccines Doses

4.6.2 Hepatitis B Pediatric – Number of Children Being Vaccinated

4.6.3 Market Size of Hepatitis B Pediatric Vaccines

4.7 Canada – Varicella / Chicken Pox Vaccines & Forecast


4.7.1 Number of Varicella / Chicken Pox Vaccines Doses

4.7.2 Varicella / Chicken Pox – Number of Children Being Vaccinated

4.7.3 Market Size of Varicella / Chicken Pox Vaccines

4.8 Canada – Meningococcal C (Men–C) Vaccines & Forecast

4.8.1 Number of Meningococcal C (Men–C) Vaccines Doses

4.8.2 Meningococcal C (Men–C) – Number of Children Being Vaccinated

4.8.3 Market Size of Meningococcal C (Men–C) Vaccines

5. Growth Drivers of Canada Pediatric Vaccines Market

5.1 Immunization & Reduce Preventable Infectious Diseases

5.1.1 Immunization — a Collective Protection

5.1.2 Immunization in Public Health — Past & Present

5.1.3 Immunization—a Shared Responsibility

5.2 The Vaccine Injury Compensation Program

5.3 Transforming of Vaccine Technologies

5.4 Continuous Focus on Effective Communication Strategies

6. Challenges of Canada Pediatric Vaccines Market

6.1 Impediment in Pediatric Vaccine Research & Development

6.2 Barriers to New Entrants in the Pediatric Vaccines Market

6.3 Hurdles to Optimal use of Licensed Vaccines

6.3.1 Technical Obstacles

6.3.2 Economic obstacles

6.3.3 Cultural Obstacles

6.4 Complexity of Vaccine Development & Approval System Thwarts Product Development

6.4.1 Legal Obstacles

6.4.2 General Technical Barriers

6.4.3 Economic Barriers

6.4.4 Regulatory Barriers

6.5 Shortening the Timeline for Vaccine Development


List of Figures

Figure 2–1: Canada – Pediatric Vaccines Market (Million US$), 2010 – 2014

Figure 2–2: Canada – Forecast for Pediatric Vaccines Market (Million US$), 2015 – 2020

Figure 3–1: Canada – Pediatric Vaccines Market Share (Percent), 2010 – 2014

Figure 3–2: Canada – Forecast for Pediatric Vaccines Market Share (Percent), 2015 – 2020

Figure 4–1: Canada – Number of MMR Vaccines Doses (Million Doses), 2010 – 2014

Figure 4–2: Canada – Forecast for Number of MMR Vaccines Doses (Million Doses), 2015 – 2020

Figure 4–3: Canada – Number of Children Being Vaccinated with MMR Vaccines (Million), 2010 – 2014.

.............................................................................................................. Error! Bookmark not defined.

Figure 4–4: United States – Forecast for Number of Children Being Vaccinated with MMR Vaccines

(Million), 2015 – 2020

Figure 4–5: Canada – Measles, Mumps & Rubella (MMR) Vaccines Market (Million US$), 2010 – 2014


Figure 4–6: Canada – Forecast for Measles, Mumps & Rubella (MMR) Vaccines Market (Million US$),

2015 – 2020

Figure 4–7: Canada – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2010

– 2014

Figure 4–8: Canada – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million

Doses), 2015 – 2020

Figure 4–9: Canada – Number of Children Being Vaccinated with Haemophilus Influenzae Type B

Vaccines (Million), 2010 – 2014

Figure 4–10: Canada – Forecast for Number of Children Being Vaccinated with Haemophilus Influenzae

Type B Vaccines (Million), 2015 – 2020

Figure 4–11: Canada – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2010 – 2014

Figure 4–12: Canada – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$),

2015 – 2020

Figure 4–13: Canada – Number of Doses of Polio Vaccines (Million Doses), 2010 – 2014

Figure 4–14: Canada – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2015 – 2020


Figure 4–15: Canada – Number of Children Being Vaccinated with Polio Vaccines (Million), 2010 – 2014


Figure 4–16: Canada – Forecast for Number of Children Being Vaccinated with Polio Vaccines (Million),

2015 – 2020

Figure 4–17: Canada – Polio Vaccines Market (Million US$), 2010 – 2014

Figure 4–18: Canada – Forecast for Polio Vaccines Market (Million US$), 2015 – 2020

Figure 4–19: Canada – Number of Doses of DTaP Vaccines (Million Doses), 2010 – 2014


Figure 4–20: Canada – Forecast for Number of Doses of DTaP Vaccines (Million Doses), 2015 – 2020


Figure 4–21: Canada – Number of Children Being Vaccinated with DTaP Vaccines (Million Doses), 2010 –

2014

Figure 4–22: Canada – Forecast for Number of Children Being Vaccinated with DTap Vaccines (Million

Doses), 2015 – 2020

Figure 4–23: Canada – Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million US$), 2010 –

2014

Figure 4–24: Canada – Forecast for Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million

US$), 2015 – 2020

Figure 4–25: Canada – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2014

Figure 4–26: Canada – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2015 –

2020

Figure 4–27: Canada – Number of Children Being Vaccinated with Pneumococcal Vaccines (Million), 2010

– 2014

Figure 4–28: Canada – Forecast for Number of Children Being Vaccinated with Pneumococcal Vaccines

(Million), 2015 – 2020

Figure 4–29: Canada – Pneumococcal Vaccines Market (Million US$), 2010 – 2014

Figure 4–30: Canada – Forecast for Pneumococcal Vaccines Market (Million US$), 2015 – 2020

Figure 4–31: Canada – Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses), 2010 – 2014


Figure 4–32: Canada – Forecast for Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses),

2015 – 2020

Figure 4–33: Canada – Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines (Million),

2010 – 2014

Figure 4–34: Canada – Forecast for Number of Children Being Vaccinated with Hepatitis B Pediatric


Figure 4–35: Canada – Hepatitis B Pediatric Vaccines Market (Million US$), 2010 – 2014

Figure 4–36: Canada – Forecast for Hepatitis B Pediatric Vaccines Market (Million US$), 2015 – 2020

Figure 4–37: Canada – Number of Doses of Varicella Vaccines (Million Doses), 2010 – 2014

Figure 4–38: Canada – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2015 – 2020

Figure 4–39: Canada – Number of Children Being Vaccinated with Varicella Vaccines (Million), 2010 –

2014

Figure 4–40: Canada – Forecast for Number of Children Being Vaccinated with Varicella Vaccines

(Million), 2015 – 2020

Figure 4–41: Canada – Varicella Vaccines Market (Million US$), 2010 – 2014

Figure 4–42: Canada – Forecast for Varicella Vaccines Market (Million US$), 2015 – 2020


Figure 4–43: Canada – Number of Doses of Meningococcal C (Men–C) Vaccines (Million Doses), 2010 –

2014

Figure 4–44: Canada – Forecast for Number of Doses of Meningococcal C (Men–C) Vaccines (Million

Doses), 2015 – 2020

Figure 4–45: Canada – Number of Children Being Vaccinated with Meningococcal C (Men–C) Vaccines

(Million), 2010 – 2014

Figure 4–46: Canada – Forecast for Number of Children Being Vaccinated with Meningococcal C (Men–C)


Figure 4–47: Canada – Meningococcal C (Men–C) Vaccines Market (Million US$), 2010 – 2014

Figure 4–48: Canada – Forecast for Meningococcal C (Men–C) Vaccines Market (Million US$), 2015 –

2020


List of Tables

Table 4–1: Canada – Number of Measles Cases (Number), 1999 – 2013

Table 4–2: Canada – Number of Mumps Cases (Number), 1999 – 2013

Table 4–3: Canada – Number of Rubella Cases (Number), 1999 – 2013

Table 4–4: Canada – Number of Polio Cases (Number), 2001 – 2013

Table 4–5: Canada – Number of Diphtheria Cases (Number), 1999 – 2013

Table 4–6: Canada – Number of nTetanus Cases (Number), 1999 – 2013

Table 4–7: Canada – Number of tTetanus Cases (Number), 1999 – 2013

Table 4–8: Canada – Number of Pertussis Cases (Number), 1999 – 2013

Table 5–1: Canada – Incidence of Selected Vaccine–preventable Disease, Pre–vaccine era compared with

Pre-Vaccine Era to 2013

Table 5–2: Improvement Strategies or Requirements – the Joint Commission and the Project’s

Collaborating Organizations


Order Form

Scan and e-mail this page to [email protected], alternatively one can also write the Contact

Information in an e-mail and mail it.

Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to

[email protected]

Format

Report Title: Canada Pediatric Vaccines Market, Doses, Immunization

(Vaccinated), Cases & Forecast

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User License)

US$ 1,000 US$ 1,100 US$ 1,100 US$ 1,800

For ordering this report: Three easy ways to place your order:

1) Order online by Credit Card (Visa, MasterCard, etc.):

http://www.renub.com/report/canada-pediatric-vaccines-market-doses-immunization-

vaccinated-cases-forecast-162

2) Order by Wire Transfer:

http://www.renub.com/report/wiretransfer.aspx?id=162&pid=1621

To pay by Wire Transfer, please, fill in your contact details in the form below:



http://www.renub.com/report/canada-pediatric-vaccines-market-doses-immunization-vaccinated-cases-forecast-162

http://www.renub.com/report/canada-pediatric-vaccines-market-doses-immunization-vaccinated-cases-forecast-162

http://www.renub.com/report/wiretransfer.aspx?id=162&pid=1621


Bank Details

Account Name: Renub Research

A/C No.: 109102000023296

Name of Bank: IDBI Bank Ltd.

Swift Code: IBKLINBB010

Bank Address: 4th Floor

Indian Red Cross Building

1 Red Cross Road

Opposite Parliament Street

New Delhi – 110001

India

Contact Information

First Name: Last Name:

Email:

Job Title:

Company:

Address:

City:

Postal/Zip Code:

Country:

Phone:

Mobile:

Fax:

Report Format:

Your message:


3) Order by Check

Please post the check accompanied by this form, to:

Company Address: Renub Research

1st Floor

C-86, Sector -10

Noida - 201301

Uttar Pradesh

India

Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at

[email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us

Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090

LinkedIn: http://www.linkedin.com/company/renub-research

Twitter: http://twitter.com/RenubResearch


http://www.facebook.com/pages/Renub-Research/233380966701090

http://www.linkedin.com/company/renub-research

http://twitter.com/RenubResearch


Healthcare

Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast